We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Prolonged Cell Division Arrest Prevents Development of Cancers Caused by Epstein-Barr Virus

By LabMedica International staff writers
Posted on 02 Feb 2016
A mechanism has been identified that helps explain why despite most people having been infected with Epstein-Barr virus (EBV), very few develop the lymphomas and other cancers the virus can cause.

EBV was the first human tumor virus discovered. More...
Although nearly all adults are infected with EBV, very few go on to develop disease, for reasons that are only now beginning to be understood.

Infection with EBV induces a period of very rapid cell division, which requires an increased supply of metabolites, such as nucleotides, amino acids, and lipids. Investigators at Duke University (Durham, NC, USA) found that EBV-infected cells that were unable to meet this increased metabolic demand were forced to stop proliferating and underwent a permanent growth arrest called senescence.

They reported in the January 22, 2016, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that arrested cells had a reduced level of mitochondrial respiration and a decrease in the expression of genes involved in the TCA (Kreb's) cycle and oxidative phosphorylation. Furthermore, the growth arrest in early infected cells could be rescued by supplementing the TCA cycle. Arrested cells were characterized by an increase in the expression of p53 pathway gene targets, including sestrins. Increased sestrin expression led to activation of AMPK (5' AMP-activated protein kinase), a reduction in mTOR (mammalian target of rapamycin) signaling, and, consequently, elevated autophagy that was important for cell survival.

In assessing the metabolic changes from early infection to long-term outgrowth, the investigators found concomitant increases in glucose import and surface glucose transporter 1 (GLUT1) levels, leading to elevated glycolysis, oxidative phosphorylation, and suppression of basal autophagy.

Senior author Dr. Micah Luftig, associate professor of molecular genetics and microbiology at Duke University, said, "For the most part, a healthy immune system stops Epstein-Barr virus from making much headway. In fact, many of the cancers linked to EBV are found mostly in immune-compromised patients whose ability to fight it off has been weakened. But another answer may be this newly discovered senescence trigger."

Related Links:

Duke University 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Urine Analyzer
respons® UDS100
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New research demonstrates that an electrical “fingerprint” on extracellular vesicles can be exploited to enrich cancer-associated signals (Image Credit: Shutterstock)

Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer

Pancreatic cancer is often diagnosed only after it has spread, contributing to a five-year survival rate of 13%. Standard blood-based analyses can struggle to distinguish tumor signals from the background... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.